A. Introduction
It has become apparent from studies in vitro that the survival, proliferation and differentiation of progenitor cells and functional activation of the various mature cell types of the haemopoietic system are controlled by a group of glycoprotein regulators, notably erythropoietin, T cell growth factor (IL2) and the colony-stimulating factors (CSFs) [1, 2] . Four CSFs with distinct biochemical and biological properties have been purified: M-CSF is a selective proliferative stimulus for macrophages [3] ; G-CSF for granulocytes [4] ; GM-CSF for both granulocytes and macrophages [5] ; while multi-CSF (also known as interleukin-3 [6] , burst-promoting activity [7] , P cell-stimulating factor [8] , mast cell growth factor [9] and haemopoietic cell growth factor [10] ) stimulates the proliferation not only of neutrophilic granulocytes and macrophages, but also eosinophils, megakaryocytes, erythroid and mast cells. GM-CSF synthesized by mouse lung tissue is a glycoprotein of molecular weight 23000 [5] and is required continuously for the in vitro proliferation of progenitor cells of granulocytes and macrophages, controls the irreversible commitment of these progenitors to the formation of mature granulocytes and macrophages [11] and regulates the functional activity of the mature end cells. Although it has been possible to purifY all four CSFs, detailed analysis of many aspects of the biology and biochemistry of these factors has been hampered by the limited quantities available. This problem can be largely circumvented by molecular cloning of the corresponding gene sequences and by using the cloned gene sequence to direct the synthesis of the corresponding factor. We have previously isolated cDNA clones containing partial copies of the GM-CSF mRNA from mouse lung [12] . In this paper we report the isolation of a cDNA clone which contains all of the information required to direct the synthesis of biologically active GM-CSF in simian COS cells [13] .
B. Results

Cloning of Murine GM-CSF cDNA Sequences
We have recently isolated two cDNA clones complementary to the GM-CSF mRNA from the lungs of endotoxin-treated mice [12] . The structure of this mRNA is illustrated in Fig. l . We have previously shown by Northern blot analysis that this mRNA is approximately 1200 nucleotides in length [12] , of which 100-200 nucleotides are presumably contributed by the poly (A) tail. Nucleotide sequence analysis of the two cDNA clones (pGM37 and pGM38 in The sequence presented is of the mature protein and is that predicted by nucleotide sequence analysis [12] of clones pGM37 and pGM38. Owing to a nucleotide sequence difference between the two clones, residue 116 could be either glycine or serine [12] this mRNA indicated that the 3' untranslated region of the mRNA is 319 nucleotides in length and the region encoding the mature protein is 354 nucleotides, leaving some 350 nucleotides for the putative NH2 terminal signal peptide and the 5' untranslated region [12] . The amino acid sequence of GM-CSF deduced from the nucleotide sequence of the mRNA is given in Fig. 2 , starting with the first amino acid of the mature protein [14] . The protein is predicted to be 118 amino acids in length, with a molecular weight of 13 500. The cDNA sequence in clone pGM37 extends about 20 nucleotides 5' to the region encoding the mature protein, into the region encoding the signal peptide, but does not extend to the translational initiation codon.
As a prelude to the direct expression of the cloned GM-CSF gene sequence in cell culture, we needed to isolate a cDNA clone containing the entire coding region of the GM-CSF mRNA, including the translationGly al initiation codon. In order to isolate more GM-CSF cDNA clones we have made use of a cloned T lymphocyte line, LB3 [15] , in which the synthesis of high levels of GM-CSF mRNA is inducible by concanavalin A (see Fig. 2 in reference [12] ). We estimate the abundance of GM-CSF mRNA in con-A-stimulated LB3 RNA to be at least two orders of magnitude greater than in lung RNA. We therefore constructed a library of cDNA clones complementary to con-Astimulated LB3 RNA, and screened this library for GM-CSF clones by colony hybridization using a fragment of DNA from pGM38 as a probe. Of 24 GM-CSF cDNA clones purified and examined, one (pGM3.2) appears to contain a substantial, if not complete, copy of the GM-CSF mRNA. The region of GM-CSF mRNA contained in this clone, determined by mapping the location of various restriction endonuclease sites, is illustrated in Fig. 1 .
II. Direct Expression ofGM-CSF in COS Cells
In order to be able to express eukaryotic cDNA sequences in cell culture, we have constructed a vector (pJL) which utilizes the late promoter of the simian virus SV40 to transcribe inserted DNA sequences (Fig. 3) . The vector contains the {3-lactamase gene and origin of DNA replication from the bacterial plasmid pAT153 [16] , the SV40 origin of DNA replication and T antigen coding sequences [17] and a "multicloning site" adjacent to the SV40 late promoter. This multicloning site contains cleavage sites for several restriction endonucleases suitable for insertion of foreign DNA sequences: EcoRI, Bam HI, Sac I, XbaI, SalI and Sma!. When introduced into cultured simian cells, such as CVl or COS [13] , this vector is able to replicate and to transcribe any DNA sequence inserted at the multicloning site. Provided that translational start and stop codons are included, the inserted sequence will be translated. The cDNA sequence of clone pGM3.2 has been installed in the multicloning site of pJL with the GM-CSF coding region in the same orientation as transcription from the late promoter. This recombinant was introduced into COS cells essentially as described by Dana and Sompayrac [18] and the culture medium assayed for GM-CSF activity 48 h after transfection. As negative controls, COS cells were also transfected with pJL DNA alone or with two different recombinant plasmids containing incomplete copies of the GM-CSF mRNA; COS cells which received no DNA were also assayed for GM-CSF activity. The various conditioned media were assayed for GM-CSF activity using both the FD cell line, which is absolutely dependent upon the presence of either GM-CSF or multi-CSF for growth (A. Hapel, personal communications) and the 32D CL3 cell line [19] , which is responsive only to multi-CSF. As shown in Fig. 4 , the medium for COS cells transfected with pGM3.2 DNA was able to support the growth of FD cells whereas media from all of the negative controls were completely inactive. As expected, the medium from pGM3.2-transfected COS cells was inactive on 32D CL3 cells (not shown), indicating that the active factor was GM-CSF rather than multi-CSF. The medium from pGM3.2-transfected COS cells also stimulated the formation of morphologically identifiable granulocyte and macrophage colonies in agar cultures containing bone marrow cells (Table I) [5] , the ratio of the three colony types being characteristic of GM-CSF at these concentrations [20] . The full range of biological ac- Dilution of conditioned medium tivities of the factor specified by this cloned gene is currently being assessed.
C. Conclusion
The molecular cloning of genes encoding the various haemopoietic growth regulators should allow the resolution of many outstanding questions and also bring to light hitherto unappreciated problems. By nucleotide sequence analysis of cloned gene sequences, the complete amino acid sequences of murine GM-CSF [12] and multi-CSF [21, 22] have been deduced -a goal that was essentially unattainable by conventional biochemical approaches. Comparison of these two sequences has now raised further intriguing issues. As we have previously discussed [12] , neither the primary amino acid sequences nor the predicted secondary structures of these two factors show any significant homology, despite the similar activities that they display in stimulating the growth of granulocyte and macrophage colonies from committed progenitor cells. It should now be possible to study in more detail the interaction between these two factors and their receptors, since we can now produce both GM-CSF (this paper) and multi-CSF (N. M. Gough, unpublished work) in a clonally pure form upon introduction of the cloned gene sequences into COS cells. Moreover, by in vitro mutagenesis and expression of the mutated gene sequences it should be possible to dissect the active site (or sites) of the molecules and to ask whether their various activities are determined by the same or different active sites.
